Navigation Links
AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1
Date:5/21/2009

CARLSBAD, Calif., May 21 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that a Canadian team comprised of the Canada Research Chair in Medical Genomics, Professor Jacques Corbeil and Canada Research Chair on new viruses and antiviral resistance, Professor Guy Boivin has used its enhanced respiratory virus panel assay to test for the presence of the new Flu A - Swine H1N1 virus. "The assay for research use only detected the presence of both the circulating Flu A strains and the new Flu A - H1N1 strain," said Dr. Corbeil. He further stated that "the assay distinguished the new strain from the others as well as determined the presence of an additional 24 viruses that could potentially co-infect the patients, a factor that may increase the severity of the disease."

"This assay will be of great help in the coming flu seasons and facilitate improving hospital control strategies to understand the role of co- infections in the severity of swine flu cases and enable the selection of antiviral agents in the management of influenza infections," said Dr. Boivin.

The tests, conducted at the CHUL hospital affiliated with Laval University were part of an effort from the Canadian Institute of Health Research to promote research in this area of important societal need.

About AutoGenomics

AutoGenomics, Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine. www.autogenomics.com.


'/>"/>
SOURCE AutoGenomics
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference
2. AutoGenomics to Present at Cowen Health Care Conference on March 17, 2008
3. AutoGenomics Invited to Present at the JPMorgan Healthcare Conference
4. BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
5. Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay
6. Polycystic Kidney Disease Assay at Cornell University Uses Transgenomics Surveyor Nuclease & WAVE Technology
7. Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins
8. Celsis Introduces ReACT(TM) RNA-Based Microbial Detection Assays
9. Odyssey Thera Granted U.S. Patent for Novel GPCR Assay Strategy
10. SAFC Pharma Augments Assay Development Capabilities
11. Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 4, 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an ... monetization of intellectual property, today provided an update on ... Northern District of Texas and ... Inter Partes Re-examination ("IPR") proceedings that VTech ... IPR was initiated on only certain claims of two ...
(Date:2/4/2016)... Strasbourg, France , to the US ... Strasbourg, France , to the US company Advanced Bioscience ... announce that it acted as an advisor to Transgene on ... Strasbourg, France , to the US company Advanced Bioscience ... Transgene (Euronext: TNG), a member of Institut Mérieux, is ...
(Date:2/3/2016)... , Feb. 3, 2016  Discovery Laboratories, Inc. ... on developing aerosolized KL4 surfactant therapies for respiratory ... has approved an inducement award as a component ... its newly appointed President and Chief Executive Officer.  ... Committee on February 1, 2016 and granted as ...
(Date:2/3/2016)... YORK and HOLLISTON, Mass., Feb. 3, 2016 ... HART ), a biotechnology company developing bioengineered ... trachea and bronchus, today announced that CEO ... BIO CEO & Investor Conference on Tuesday, ... New York City . HART,s ...
Breaking Biology Technology:
(Date:2/1/2016)... 1, 2016  Today, the first day of American ... to develop a first of its kind workplace health ... Watson. In the first application of Watson ... IBM ), and Welltok will create a new offering ... cognitive analytics, delivered on Welltok,s health optimization platform. The ...
(Date:1/25/2016)... BELL, Pa. , Jan. 25, 2016   Unisys Corporation ... recognition system at John F. Kennedy (JFK) International Airport, ... Border Protection (CBP) identify imposters attempting to enter ... do not belong to them. pilot testing of ... out initially at three terminals at JFK during January 2016. ...
(Date:1/21/2016)... January 21, 2016 ... new market research report "Emotion Detection and Recognition Market by ... Tools (Facial Expression, Voice Recognition and Others), Services, ... forecast to 2020", published by MarketsandMarkets, the global ... reach USD 22.65 Billion by 2020, at a ...
Breaking Biology News(10 mins):